Team

Adi Zamir

                              
Adi Zamir is the aMoon-Roche Partnership Leader at StarFinder Lab.


She has over 20 years experience in senior positions in global and local companies specializing in technology integration and services.
For the past 7 years, she has led startups in the digital health field, and was highly engaged in the development of AI/ML and Apps.
Adi has vast knowledge and experience in various industry verticals (Finance, Government, Health etc.), focused on developing technology as an accelerator of business performance and innovation, while building and leading winning teams and achieving finance and business goals in dynamic and disruptive environments.
Adi holds a B.Ed in Science Education, an M.A. in Education from Hebrew University of Jerusalem and an M.A. in Law, from Bar Ilan University.

Roy Wiesner

                                             
Roy Wiesner is a Managing Director at aMoon Fund, Israel’s largest life sciences and healthtech VC.


He focuses on early-stage investments, primarily in digital health, diagnostics and medical devices. Prior to joining aMoon, he was CEO of a Cleantech incubator and seed-stage fund owned by CK Hutchison (Fortune 500 company), where he was also involved in forming a number of ventures. Roy was previously a corporate lawyer, specializing in M&A, Private Equity and VC transactions, working for international law firm Weil Gotshal in New York and Hong Kong, and as a partner for a prominent law firm in Tel Aviv. He holds an LL.B from the Hebrew University and a dual MBA from the LSE and Columbia University.

Alexandra
Vallon-Eberhard

               
Alexandra Vallon-Eberhard is a Senior Director of Global Business Development at Roche and the Operational Team Lead for Roche at StarFinder Lab.
She has over 15 years of international business development, investment, innovation, and managerial experience, with ten years of basic and applied Immunology and IVD research under her belt. Alexandra specializes in ecosystem partnerships, end-to-end disease management & prevention, diagnostics, and digital health. Known for quickly converting strategic plans into result-driven tactical and operational reality, Alexandra has guided many Israeli and Swiss start-ups in their financial, strategic, and operational growth, while also supporting over 40 of the Fortune 500 companies in their external growth strategy. She holds an International MBA from Bar Ilan University, a Ph.D. in Immunology and Virology from Claude Bernard Lyon I University, and was a postdoctoral associate at the Weizmann Institute of Science.